Minerva Neurosciences, INC. 8-K Filing
Ticker: NERV · Form: 8-K · Filed: Dec 22, 2025 · CIK: 1598646
Sentiment: neutral
Filing Stats: 1,051 words · 4 min read · ~4 pages · Grade level 13.3 · Accepted 2025-12-22 16:05:13
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NERV The Nasdaq
Filing Documents
- d16725d8k.htm (8-K) — 40KB
- d16725dex101.htm (EX-10.1) — 139KB
- 0001193125-25-328715.txt ( ) — 327KB
- nerv-20251222.xsd (EX-101.SCH) — 3KB
- nerv-20251222_lab.xml (EX-101.LAB) — 17KB
- nerv-20251222_pre.xml (EX-101.PRE) — 11KB
- d16725d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 10.1 Minerva Neurosciences, Inc. Amended and Restated 2013 Equity Incentive Plan, as amended. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MINERVA NEUROSCIENCES, INC. Date: December 22, 2025 By: /s/ Frederick Ahlholm Frederick Ahlholm Chief Financial Officer